Activation of AMPK in Human Placental Explants Impairs Mitochondrial Function and Cellular Metabolism

14Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: Adenosine monophosphate–activated protein kinase (AMPK) is a cellular energy sensor whose phosphorylation increases energy production. We sought to evaluate the placenta-specific effect of AMPK activation on the handling of nutrients required for fetal development. Methods: Explants were isolated from term placenta of 29 women (pregravid body mass index: 29.1 ± 9.9 kg/m 2 ) and incubated for 24 hours with 0 to 100 µmol/L resveratrol or 0 to 1 mmol/L of 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR). Following treatment, uptake and metabolism of radiolabeled fatty acids and glucose were measured. Phosphorylation of AMPK was measured by Western blotting. Adenosine diphosphate (ATP) production was assessed using the mitochondrial ToxGlo assay kit. P

Cite

CITATION STYLE

APA

Landau, D., Haghiac, M., Minium, J., Skomorovska-Prokvolit, Y., Calabuig-Navarro, V., & O’Tierney-Ginn, P. (2019). Activation of AMPK in Human Placental Explants Impairs Mitochondrial Function and Cellular Metabolism. Reproductive Sciences, 26(4), 487–495. https://doi.org/10.1177/1933719118776803

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free